Hims & Hers Health
HIMS
14.60
-1.42
-8.86%
Hims & Hers Health
US · HIMS
#1813 by market cap
Listed 1970
14.60
-1.42
-8.86%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
3 2
■ Upgrades■ Downgrades
- 3 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: J.P. Morgan moved from Buy to Hold on 2026-09-11.
Analyst consensus 12 analysts
Buy
Avg price target 29.22 +100.1%
Price target rangecurrent 14.60
Low24.00
Avg29.22
High40.00
Buy 25%
Hold 75%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | KeyBanc | -- | Hold | -- |
| 2026-11-10 | CCORF | -- | Buy | 40.00 |
| 2026-11-10 | BofA Securities | -- | Hold | -- |
| 2026-11-10 | Morgan Stanley | -- | Hold | 25.00 |
| 2026-11-10 | Jefferies | -- | Hold | 24.00 |
| 2026-11-10 | Evercore | -- | Hold | 27.00 |
| 2026-11-10 | Needham | -- | Buy | 32.00 |
| 2026-11-10 | Leerink Partners | -- | Hold | 24.00 |
| 2026-11-10 | Barclays | -- | Buy | 35.00 |
| 2026-11-10 | J.P. Morgan | -- | Hold | 24.00 |
| 2026-11-09 | BTIG | -- | Hold | -- |
| 2026-11-06 | BofA Securities | -- | Hold | 32.00 |
| 2026-10-29 | Barclays | -- | Buy | 35.00 |
| 2026-10-28 | BofA Securities | -- | Hold | 32.00 |
| 2026-10-15 | BofA Securities | -- | Hold | 32.00 |
| 2026-10-08 | BofA Securities | -- | Hold | 32.00 |
| 2026-09-25 | BofA Securities | -- | Hold | 32.00 |
| 2026-09-15 | BofA Securities | -- | Hold | 32.00 |
| 2026-09-11 | Truist Financial | -- | Hold | 32.00 |
| 2026-09-11 | J.P. Morgan | -- | Hold | 32.00 |
| 2026-09-03 | Jefferies | -- | Hold | 31.00 |
| 2026-09-02 | KeyBanc | -- | Hold | -- |
| 2026-08-25 | Truist Financial | -- | Hold | 32.00 |
| 2026-08-20 | Barclays | -- | Buy | 35.00 |
| 2026-08-12 | Citi | -- | Hold | 33.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-11 | J.P. Morgan | Buy → Hold | 32.00 |
| 2026-03-10 | BofA Securities | Sell → Hold | 23.00 |
| 2026-03-09 | Citi | Sell → Hold | 24.00 |
| 2026-03-09 | Needham | Hold → Buy | 30.00 |
| 2026-02-23 | BTIG | Buy → Hold | 60.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-09 | After close | ±13.59% | -16.61% (beat) |
| 2026/Q2 | 2026-08-10 | After close | ±14.74% | -3.97% (in line) |
| 2026/Q1 | 2026-05-11 | After close | ±17.06% | -14.10% (in line) |
| 2025/Q4 | 2026-02-23 | After close | ±15.09% | -0.32% (in line) |
| 2025/Q3 | 2025-11-03 | After close | ±15.00% | -3.60% (in line) |
| 2025/Q2 | 2025-08-04 | After close | ±17.79% | -12.36% (in line) |
| 2025/Q1 | 2025-05-05 | After close | ±20.24% | +18.12% (in line) |
| 2024/Q4 | 2025-02-24 | After close | ±20.20% | -22.32% (beat) |
| 2024/Q3 | 2024-11-04 | After close | ±19.62% | -0.58% (in line) |
| 2024/Q2 | 2024-08-05 | After close | ±22.00% | -5.38% (in line) |
| 2023/Q2 | 2023-08-07 | After close | ±19.95% | -5.82% (in line) |
| 2023/Q1 | 2023-05-08 | After close | ±18.06% | -10.13% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.
Hims & Hers Health discussion 0 comments